The medication handles appetite and the B6 handles nausea, but everything else, protein intake, hydration, movement, sleep, and stress management, determines how much benefit you actually extract from the treatment
Semaglutide is FDA-approved under two brand names: Ozempic (approved 2017 for type 2 diabetes at doses up to 1 mg weekly) and Wegovy (approved 2021 for chronic weight management at doses up to 2.4 mg weekly)
Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia
Heise T, DeVries JH, Urva S, Li J, Pratt EJ, Thomas MK, Mather KJ, Karanikas CA, Dunn J, Haupt A et al (2023) Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes
Albiglutide comprises two copies of GLP-1 fused as tandem repeats to the N terminus of albumin [3], while dulaglutide is a recombinant fusion protein consisting of two GLP-1 peptides covalently linked to a human IgG4-Fc heavy-chain variant [3]